Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedema.
| Data(s) |
2009
|
|---|---|
| Identificador |
http://serval.unil.ch/?id=serval:BIB_A7BA8C35583C isbn:0194-911X pmid:19581503 doi:10.1161/HYPERTENSIONAHA.109.135244 isiid:000269089100011 http://my.unil.ch/serval/document/BIB_A7BA8C35583C.pdf http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_A7BA8C35583C1 |
| Idioma(s) |
en |
| Direitos |
Restricted: indefinite embargo info:eu-repo/semantics/restrictedAccess |
| Fonte |
Hypertension, vol. 54, no. 3, pp. 468-470 |
| Palavras-Chave | #adamantane/adverse effects ; adamantane/analogs & derivatives ; angioedema/chemically induced ; angiotensin-converting enzyme inhibitors/adverse effects ; antigens ; CD26/antagonists & inhibitors ; antigens ; CD26/metabolism ; dipeptidyl-peptidase IV inhibitors/adverse effects ; drug synergism ; humans ; models ; biological ; nitriles/adverse effects ; pyrrolidines/adverse effects ; risk factors |
| Tipo |
info:eu-repo/semantics/article article |
